It seems like some of the medications out there have such nasty "possible" side effects that it sure would make you think twice about using the medication. You would think that they could come up with better medications that doesn't have such horrible "possible" side effects. My favorite is the medication you see advertised all the time that is suppose to help treat ADHD. One of the "rare" but "possible" side effects is sudden death! Yeah, that's totally worth it to help treat someone's ADHD!!
Cathy (Central Time Zone) A&I BSG June Happy Hikers
The U.S. Food and Drug Administration (FDA) has made changes to the label for the single-pill HIV antiretroviral combination therapy Atripla (efavirenz/emtricitabine/tenofovir). Among those changes and additions are:
An advisory against taking Atripla with Stribild (elvitegravir/cobicistat/emtricitabine/ten ofovir). Information on drug interaction for raltegravir, boceprevir and telaprevir. Additional information about a rash warning, advising those with a life-threatening reaction such as Stevens-Johnson syndrome to consider alternative HIV therapy. A statement that the appropriate dosing for a combination of efavirenz and boosted Invirase (saquinavir/ritonavir) has not been established. Information about dosing with boosted Kaletra (lopinavir/ritonavir), with an advisory that those taking the pair in combination with Atripla should be monitored for adverse reactions. In an addition to the advisory that HIV-positive mothers should not breast-feed their infants because of the risk of transmitting the virus, the FDA states that studies in rats have shown that efavirenz is secreted in milk and that human studies have shown that both tenofovir and emtricitabine are excreted in breast milk. Because the risks of infant exposure to these agents are unknown, mothers should not breast-feed while taking Atripla.
SparkPeople, SparkCoach, SparkPages, SparkPoints, SparkDiet, SparkAmerica, SparkRecipes, DailySpark, and other marks are trademarks of SparkPeople, Inc. All Rights Reserved.
SPARKPEOPLE is a registered trademark of SparkPeople, Inc. in the United States, European Union, Canada, and Australia. All rights reserved.